The historical rank and industry rank for 4DMedical's EV-to-EBIT or its related term are showing as below:
ASX:4DX'
s EV-to-EBIT Range Over the Past 10 Years
Min: -17.85 Med: -4.41 Max: -1.07
Current: -6.61
During the past 3 years, the highest EV-to-EBIT of 4DMedical was -1.07. The lowest was -17.85. And the median was -4.41.
ASX:4DX's EV-to-EBIT is ranked worse than 100% of 460
companies
in the Medical Devices & Instruments industry
Industry Median: 20.385
vs ASX:4DX: -6.61
The historical data trend for 4DMedical's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, 4DMedical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
4DMedical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 4DMedical's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where 4DMedical's EV-to-EBIT falls into.
4DMedical EV-to-EBIT Calculation
4DMedical's EV-to-EBIT for today is calculated as:
4DMedical's current Enterprise Value is A$201.29 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. 4DMedical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-30.46 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
4DMedical (ASX:4DX) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
4DMedical's Enterprise Value for the quarter that ended in Dec. 2023 was A$236.16 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. 4DMedical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-30.46 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
4DMedical EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of 4DMedical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
4DMedical Ltd is a company whose principal activities is medical research technology and the development of a non?invasive respiratory imaging solution using four?dimensional imaging. The four-dimensional lung imaging technology utilises mathematics models and algorithms to convert X-ray scans into quantitative data which helps the physicians to manage patients with respiratory diseases and diseases of the lung.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:4DX has been successfully added to your